Erratum: Preclinical Safety and Efficacy of Human CD34+ Cells Transduced with Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome (Molecular Therapy (2013) 21 (175-184) DOI:10.1038/mt.2012.23)

Samantha Scaramuzza, Luca Biasco, Anna Ripamonti, Maria C. Castiello, Mariana Loperfido, Elena Draghici, Raisa J. Hernandez, Fabrizio Benedicenti, Marina Radrizzani, Monica Salomoni, Marco Ranzani, Cynthia C. Bartholomae, Elisa Vicenzi, Andrea Finocchi, Robbert Bredius, Marita Bosticardo, Manfred Schmidt, Christof Von Kalle, Eugenio Montini, Alessandra BiffiMaria G. Roncarolo, Luigi Naldini, Anna Villa, Alessandro Aiuti

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1159
Number of pages1
JournalMolecular Therapy
Volume24
Issue number6
DOIs
Publication statusPublished - Jun 1 2016

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Genetics
  • Drug Discovery
  • Pharmacology

Cite this

Scaramuzza, S., Biasco, L., Ripamonti, A., Castiello, M. C., Loperfido, M., Draghici, E., Hernandez, R. J., Benedicenti, F., Radrizzani, M., Salomoni, M., Ranzani, M., Bartholomae, C. C., Vicenzi, E., Finocchi, A., Bredius, R., Bosticardo, M., Schmidt, M., Von Kalle, C., Montini, E., ... Aiuti, A. (2016). Erratum: Preclinical Safety and Efficacy of Human CD34+ Cells Transduced with Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome (Molecular Therapy (2013) 21 (175-184) DOI:10.1038/mt.2012.23). Molecular Therapy, 24(6), 1159. https://doi.org/10.1038/mt.2016.96